GnRH-Agonist Triggering to Avoid Ovarian Hyperstimulation Syndrome: A Review of the Evidence

By  

Current Drug Targets, Vol. 14, Iss. 8, 2013-07 ,pp. : 843-849

Bentham Science Publishers

Access to resources Recommend Favorite

Case Report: Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase

By Lainas TG   Sfontouris IA   Zorzovilis IZ   Petsas GK   Lainas GT   Alexopoulou E   Kolibianakis EM  

Reproductive BioMedicine Online, Vol. 19, Iss. 6, 2009-12 ,pp. : 789-795

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol

By Lainas TG   Sfontouris IA   Zorzovilis IZ   Petsas GK   Lainas GT   Iliadis GS   Kolibianakis EM  

Reproductive BioMedicine Online, Vol. 18, Iss. 1, 2009-01 ,pp. : 15-20

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis

By Franco JG   Baruffi RLR   Mauri AL   Petersen CG   Felipe V   Cornicelli J   Cavagna M   Oliveira JBA  

Reproductive BioMedicine Online, Vol. 13, Iss. 5, 2006-11 ,pp. : 618-627

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis

By Griesinger G   Diedrich K   Tarlatzis BC   Kolibianakis EM  

Reproductive BioMedicine Online, Vol. 13, Iss. 5, 2006-11 ,pp. : 628-638

Reproductive Healthcare Ltd

Access to resources Recommend Favorite